Complex I is rate-limiting for oxygen consumption in the nerve terminal

The role of electron transport chain components in regulating oxygen consumption in nerve terminals remains incompletely understood. Prior research has shown that mitochondrial dysfunction contributes to neurodegenerative conditions. However, the specific contribution of each complex to overall bioenergetic control is unclear. No prior work had resolved the relative influence of individual electron transport chain complexes on oxygen consumption in nerve terminals. This uncertainty drove the need to quantify the control exerted by each complex. Synaptosomes provide a model system to study these mechanisms in a controlled setting. Researchers have not yet determined the precise flux control coefficients for each complex in this context. The lack of detailed data on inhibition thresholds also represents a knowledge gap. Understanding these parameters could clarify how mitochondrial dysfunction affects neuronal function.

This study aimed to quantify the control exerted by electron transport chain complexes over oxygen consumption in nerve terminals. The researchers focused on synaptosomes as a model system to isolate these effects. They sought to determine flux control coefficients for each complex to assess their relative influence. Inhibition thresholds were also measured to understand when changes in activity impact oxygen consumption. The goal was to identify which complex has the greatest regulatory role. This information could help explain how mitochondrial dysfunction affects nerve terminals. The study aimed to provide a framework for understanding bioenergetic control in this system. These findings may inform future research on neurodegenerative disorders linked to mitochondrial dysfunction.

Metabolic control analysis was used to assess the influence of electron transport chain complexes. Oxygen consumption rates were measured in rat brain synaptosomes under controlled conditions. Inhibitors were applied to titrate the activity of each complex individually. Flux control coefficients were calculated based on the resulting changes in oxygen consumption. Inhibition thresholds were determined by identifying when activity reductions caused significant effects. The study focused on four complexes: I, II/III, III, and IV. Each complex was tested with specific inhibitors to isolate its contribution. The data were analyzed to determine the relative control each complex exerted over oxygen consumption.

Complex I had the highest flux control coefficient at 0.30 +/- 0.07. Complex II/III had a coefficient of 0.20 +/- 0.03, and complex III had 0.20 +/- 0.05. Complex IV had the lowest coefficient at 0.08 +/- 0.05. These values indicate that complex I exerts the most control over oxygen consumption. Inhibition thresholds were lowest for complex I, at approximately 10%. Complex II/III had an inhibition threshold of approximately 30%. Complex III required approximately 35% inhibition before changes were observed. Complex IV had the highest threshold, between 50-65%, before oxygen consumption was affected.

The findings suggest that complex I plays a dominant role in regulating oxygen consumption in nerve terminals. The high flux control coefficient supports this conclusion. The low inhibition threshold for complex I further emphasizes its regulatory importance. These results align with the hypothesis that complex I deficiencies may impact bioenergetics in nerve terminals. The study does not claim that other complexes are unimportant, but their influence is less pronounced. The data support the idea that complex I is a critical node in this system. The authors propose that complex I dysfunction could compromise oxygen consumption in neurodegenerative disorders. These conclusions are based on the observed flux control coefficients and inhibition thresholds.